AHA/ASA Journals

1 month ago | ahajournals.org | Ernesto L. Schiffrin

Get full access to this articleView all available purchase options and get full access to this article. References1. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–450. doi: 10.1161/CIRCULATIONAHA.115.0189122. Schiffrin EL.

1 month ago | ahajournals.org | Maggie H. Wang |Neal W. Dickert |Shivani Patel |Ambarish Pandey

Research ArticleOpen AccessNonstandard Abbreviations and AcronymsDCIdistressed community indexGWTG‐HFGet With The Guidelines‐Heart FailureClinical Perspective•In the GWTG‐HF (Get With The Guidelines‐Heart Failure) registry, patients from minoritized racial and ethnic groups, aside from Black patients, were less likely than White patients to be referred to outpatient heart failure management programs at hospital discharge.

1 month ago | ahajournals.org | Eva Rocha

In this new episode of Aha! with JAHA, Dr. Eva Rocha interviews Dr. Allison E. Gaffey (Yale School of Medicine; VA Connecticut Healthcare System) and Dr. Diana Wolfe (Albert Einstein College of Medicine) about the new AHA Scientific Statement, “Optimizing Psychological Health Across the Perinatal Period: An Update on Maternal Cardiovascular Health”.

1 month ago | ahajournals.org | Jose Romero |José Romero

Optimal Duration of Dual Antiplatelet Therapy After Carotid Artery Stenting: A Nationwide Cohort StudyYoo et al conducted a retrospective study using a nationwide claims database that captures 97% of the Korean population to assess the duration of dual antiplatelet therapy (DAPT) after revascularization procedures with stent placement for carotid artery disease.

2 months ago | ahajournals.org | Nathan Smith

Get full access to this articleView all available purchase options and get full access to this article. Supplemental MaterialFile (circcvqo-2024-011636-s01.pdf)Appendices A–DReferences 91–113References1. Cutler DM, Rosen AB, Vijan S. The value of medical spending in the United States, 1960-2000. N Engl J Med. 2006;355:920–927. doi: 10.1056/NEJMsa0547442. U.S. Food and Drug Administration. Premarket approval (PMA). FDA; 2019. Cited May 24, 2023.